WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

1M
6M
1Y
All
NAV: 29 Apr '26
₹14.78
Min. for SIP
₹100
Fund size (AUM)
₹556.42 Cr
Expense ratio
0.96%
Rating
--

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
3 months₹15,000₹15,480
+3.20%
6 months₹30,000₹30,840
+2.80%
1 year₹60,000₹62,743
+4.57%

Holdings (55)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity12.35%
JB Chemicals & Pharmaceuticals Ltd.HealthcareEquity8.90%
Lupin Ltd.HealthcareEquity5.77%
Divi's Laboratories Ltd.HealthcareEquity5.31%
Apollo Hospitals Enterprise Ltd.HealthcareEquity4.24%
Laurus Labs Ltd.HealthcareEquity3.93%
Fortis Healthcare Ltd.HealthcareEquity3.85%
Max Healthcare Institute Ltd.HealthcareEquity3.79%
Glenmark Pharmaceuticals Ltd.HealthcareEquity3.17%
Krishna Institute of Medical Sciences LtdHealthcareEquity3.16%
Aurobindo Pharma Ltd.HealthcareEquity3.02%
Sai Life Sciences Ltd.HealthcareEquity2.77%
Acutaas Chemicals Ltd.HealthcareEquity2.61%
CORONA Remedies Ltd.HealthcareEquity2.27%
Ipca Laboratories Ltd.HealthcareEquity2.17%
Ajanta Pharma Ltd.HealthcareEquity2.11%
Aurobindo Pharma Ltd.HealthcareFutures2.03%
Emcure Pharmaceuticals Ltd.HealthcareEquity1.89%
Narayana Hrudayalaya Ltd.HealthcareEquity1.72%
Shaily Engineering Plastics Ltd.ChemicalsEquity1.58%
Thyrocare Technologies Ltd.HealthcareEquity1.56%
Neuland Laboratories Ltd.HealthcareEquity1.42%
Navin Fluorine International Ltd.ChemicalsEquity1.41%
Aether Industries Ltd.ChemicalsEquity1.38%
Pfizer Ltd.HealthcareEquity1.35%
Dr. Lal Pathlabs Ltd.HealthcareEquity1.34%
Strides Pharma Science Ltd.HealthcareEquity1.24%
Kovai Medical Center & Hospital Ltd.HealthcareEquity1.20%
Astrazeneca Pharma India Ltd.HealthcareEquity1.07%
Vijaya Diagnostic Centre Ltd.HealthcareEquity0.94%
Dr. Reddy's Laboratories Ltd.HealthcareFutures0.89%
Reserve Bank of IndiaFinancialT-Bills0.89%
Reserve Bank of IndiaFinancialT-Bills0.89%
Zydus Lifesciences Ltd.HealthcareEquity0.83%
Rainbow Children's Medicare Ltd.HealthcareEquity0.80%
Divi's Laboratories Ltd.HealthcareFutures0.78%
Dr. Reddy's Laboratories Ltd.HealthcareEquity0.74%
Poly Medicure Ltd.HealthcareEquity0.70%
Sudeep Pharma Ltd.HealthcareEquity0.67%
Supriya Lifescience Ltd.HealthcareEquity0.64%
Zota Health Care Ltd.HealthcareEquity0.55%
Aarti Pharmalabs Ltd.ServicesEquity0.48%
Max Healthcare Institute Ltd.HealthcareFutures0.39%
Reserve Bank of IndiaFinancialT-Bills0.36%
Apollo Hospitals Enterprise Ltd.HealthcareFutures0.32%
Tatva Chintan Pharma Chem Ltd.ChemicalsEquity0.21%
Orchid Pharma Ltd.HealthcareEquity0.19%
Reserve Bank of IndiaFinancialT-Bills0.18%
Reserve Bank of IndiaFinancialT-Bills0.18%
Reserve Bank of IndiaFinancialT-Bills0.18%
Alkem Laboratories Ltd.HealthcareEquity0.15%
Reserve Bank of IndiaFinancialT-Bills0.14%
Sun Pharmaceutical Industries Ltd.HealthcareFutures0.10%
Fortis Healthcare Ltd.HealthcareFutures0.07%
Reserve Bank of IndiaFinancialT-Bills0.04%
See All

Minimum investments

Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name3M6M1YAll
Fund returns+7.1%-0.7%+8.4%+44.5%
Category average (Equity Sectoral)-----2.1%--
Rank (Equity Sectoral)892--

Exit load, stamp duty and tax

Exit load

Nil

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Check past data

Fund management

PB
Piyush Baranwal
Jan 2024 - Present
View details

About WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 03 Jul 2018. Ramesh Mantri is the Current Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹32,442 Cr and the Latest NAV as of 29 Apr 2026 is ₹14.78. The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹500. ;

Investment Objective

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)--
Total AUM₹32,442.06 Cr
Date of Incorporation03 Jul 2018
Phone1800 266 3060
E-mail--
Launch Date03 Jul 2018
AddressUnit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
CustodianDeutsche Bank
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,